10-QPeriod: Q3 FY2010

UNITEDHEALTH GROUP INC Quarterly Report for Q3 Ended Sep 30, 2010

Filed November 3, 2010For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) reported strong financial performance for the nine months ended September 30, 2010, with total revenues increasing by 7% year-over-year to $70.1 billion. Net earnings grew by 25% to $3.6 billion, resulting in diluted earnings per share of $3.15. The company demonstrated robust operational efficiency, with operating earnings increasing by 27% and operating margins expanding. Key drivers of this growth included strong performance in the Health Benefits segment, particularly in public and senior markets, and solid contributions from its health services businesses like Ingenix and Prescription Solutions. The company's balance sheet remains strong, with total assets growing to $63 billion. UnitedHealth Group also actively managed its capital structure, repurchasing approximately $1.9 billion in common stock and increasing its quarterly dividend. The company is navigating the evolving healthcare landscape, including the impacts of the Patient Protection and Affordable Care Act, and appears well-positioned due to its diversified business model and focus on both health benefits and health services.

Financial Highlights

52 data points
Beta

Revenue

$23.67B

97.7% Gross Margin

Net Income

$1.28B

5.4% Net Margin

EPS (Diluted)

$1.14

Total Assets

$63.02B

Cash & Equivalents

$9.58B

Free Cash Flow

$2.70B

Financial Statements
Beta
Revenue$23.67B
Cost of Revenue$536.00M
Gross Profit$23.13B
SG&A Expenses$3.55B
Operating Expenses$21.52B
Operating Income$2.15B
Interest Expense$119.00M
Net Income$1.28B
EPS (Basic)$1.15
EPS (Diluted)$1.14
Shares Outstanding (Basic)1.11B
Shares Outstanding (Diluted)1.12B

Key Highlights

  • 1Total revenues increased by 7% to $70.1 billion for the nine months ended September 30, 2010.
  • 2Net earnings grew by 25% to $3.6 billion, with diluted EPS of $3.15.
  • 3Earnings from operations saw a significant increase of 27% to $6.1 billion.
  • 4The Health Benefits segment showed strong revenue growth (7%) and improved operating margin, driven by public and senior markets.
  • 5Significant share repurchases of $1.9 billion were made during the nine-month period.
  • 6The company's total assets grew to $63.0 billion, with a healthy shareholders' equity of $25.6 billion.
  • 7The company is actively managing its capital structure, including increased dividend payments and share repurchases.

Frequently Asked Questions

Revenue growth was primarily driven by strong organic growth in risk-based benefit offerings within its public and senior markets businesses. Additionally, growth in customers served by health services businesses, particularly pharmaceutical benefit management programs, and increased revenues from public sector programs and health care technology sales also contributed significantly.

Medical costs increased year-over-year, primarily due to growth in public and senior market businesses and medical cost inflation. However, this was partially offset by decreases in commercial risk-based membership and net favorable development of prior period medical costs. The company reported $660 million in net favorable medical cost development related to prior fiscal years for the nine-month period, driven by lower-than-expected health system utilization and more efficient claims handling.

UnitedHealth Group acknowledged the significant impacts of the Patient Protection and Affordable Care Act (Health Reform Legislation), which was signed into law in early 2010. While anticipating new opportunities for business growth, the company focused on the risks it introduces, such as potential increases in medical costs, changes in underwriting policies, and impacts on premium growth rates. The company noted that the full impact is not yet known due to complexity, pending regulations, and gradual implementation, but it is adapting its business practices in anticipation of these changes.

The company is returning capital to shareholders through share repurchases and dividend payments. During the first nine months of 2010, UnitedHealth Group repurchased approximately $1.9 billion of its common stock. Additionally, in May 2010, the company's Board of Directors increased its cash dividend and transitioned to a quarterly dividend payment cycle.